IEX •
Healthcare •
Biotechnology •
Quote as of 07/01/2026 15:59
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeIEX
Market Capitalization217.24 mln
Float73.50 mln
Earnings Date07/30/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-3.02
Reliable
Relative Strength
25
/ 100
Underperforming
Debt / Equity
1.69
High leverage
ROE
-67.33
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Codexis is a biotechnology company based in Redwood City, California, that uses its proprietary enzyme engineering technology to help pharmaceutical manufacturers produce treatments more efficiently. Its platform is used to develop and scale up specialized enzymes for a range of applications, including RNA-based medicines, and the company sells its solutions across North America, Europe, the Middle East, Africa, Asia, and Australia. Codexis works under licensing agreements with partners such as Aldevron and Pfizer, and has been operating since 2002.
